Cargando…
Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience
Unilateral peripheral facial nerve palsy jeopardizes quality of life, rendering psychological consequences such as low self-esteem, social isolation, anxiety, and depression. Among therapeutical approaches, use of Botulinum toxin type A (BoNT-A) on the nonparalyzed side has shown promising results a...
Autores principales: | de Sanctis Pecora, Carla, Shitara, Danielle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923088/ https://www.ncbi.nlm.nih.gov/pubmed/33670477 http://dx.doi.org/10.3390/toxins13020159 |
Ejemplares similares
-
Improvement of chronic facial pain and facial dyskinesia with the help of botulinum toxin application
por: Junghans, Katharina, et al.
Publicado: (2007) -
The Treatment of Facial Asymmetry with Botulinum Toxin: Current Concepts, Guidelines, and Future Trends
por: Heydenrych, Izolda
Publicado: (2020) -
Facial nerve electrodiagnostics for patients with facial palsy: a clinical practice guideline
por: Guntinas-Lichius, Orlando, et al.
Publicado: (2020) -
Treatment of Post-Facelift Facial Paralysis With Botulinum Toxin Type A
por: Mota, Wellington Menezes, et al.
Publicado: (2019) -
Botulinum Toxins for Facial Lines: A Concise Review
por: Lowe, Nicholas J., et al.
Publicado: (2012)